购物车
- 全部删除
- 您的购物车当前为空
20S Proteasome activator 1 是一种 20S 蛋白酶激活剂,对胰蛋白酶样位点、胰凝乳蛋白酶样位点和半胱天冬酶位点的 IC50 分别为 0.3 μM、0.7 μM 和 1.8 μM。20S Proteasome activator 1 通过在细胞系统中翻译来防止致病性 α-synuclein A53T 突变体积累从而减少疾病发生的概率。20S Proteasome activator 1 可用于研究神经退行性疾病。
为众多的药物研发团队赋能,
让新药发现更简单!
20S Proteasome activator 1 是一种 20S 蛋白酶激活剂,对胰蛋白酶样位点、胰凝乳蛋白酶样位点和半胱天冬酶位点的 IC50 分别为 0.3 μM、0.7 μM 和 1.8 μM。20S Proteasome activator 1 通过在细胞系统中翻译来防止致病性 α-synuclein A53T 突变体积累从而减少疾病发生的概率。20S Proteasome activator 1 可用于研究神经退行性疾病。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 281 | 现货 | |
5 mg | ¥ 663 | 现货 | |
10 mg | ¥ 985 | 现货 | |
25 mg | ¥ 1,960 | 现货 | |
50 mg | ¥ 3,320 | 现货 | |
100 mg | ¥ 4,850 | 现货 | |
500 mg | ¥ 9,870 | 现货 |
产品描述 | 20S Proteasome activator 1 is a 20S proteasome activator with IC50 of 0.3 μM for trypsin-like sites, 0.7 μM for chymotrypsin-like sites and 1.8 μM for caspase sites. 20S Proteasome activator 1 prevents the accumulation of pathogenic alpha-synuclein A53T mutants through translation in the cellular system, thereby reducing the probability of disease occurrence. The 20S Proteasome activator 1 can be used to study neurodegenerative diseases. |
靶点活性 | Caspase-like site:1.8 μM, Chymotrypsin-like site:0.7 μM, Trypsin like site:0.3 μM |
体外活性 | 在2.5-15 μM浓度和45分钟的处理时间下,20S Proteasome activator 1能够降解73%的10 μM α-synuclein,并在15 μM时降解超过80%。[1] 在5-15 μM浓度和24小时的治疗期间,20S Proteasome activator 1能够减少25%的A53T突变型α-synuclein。此外,它还表现出剂量依赖性地减少Hek-293T细胞中暂时转染A53T突变型α-synuclein质粒的α-synuclein的增加,15 μM时可达到67%的减少幅度。[1] |
别名 | 20S蛋白酶激动剂1 |
分子量 | 492.97 |
分子式 | C27H19ClF2N2OS |
CAS No. | 2761578-18-9 |
Smiles | C(CC(N(C1=CC=C(F)C=C1)C2=CC=C(F)C=C2)=O)N3C=4C(SC=5C3=CC=CC5)=CC=C(Cl)C4 |
存储 | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 50 mg/mL (101.43 mM), Sonication is recommended. ![]() | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
|
评论内容